WELLS FARGO & COMPANY/MN - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$189,546
-63.2%
74,919
-3.2%
0.00%
Q2 2023$515,357
-42.0%
77,381
+62.5%
0.00%
Q1 2023$888,422
+135.9%
47,611
+171.6%
0.00%
Q4 2022$376,609
+70.4%
17,533
-6.2%
0.00%
Q3 2022$221,000
-0.5%
18,701
+11.1%
0.00%
Q2 2022$222,000
-22.9%
16,830
+22.4%
0.00%
Q1 2022$288,000
-28.0%
13,745
-30.2%
0.00%
Q4 2021$400,000
+34.2%
19,704
+100.8%
0.00%
Q3 2021$298,000
+8.4%
9,815
+3.8%
0.00%
Q2 2021$275,000
-49.3%
9,456
-24.8%
0.00%
Q1 2021$542,000
-62.1%
12,580
-59.3%
0.00%
Q4 2020$1,430,000
+171.9%
30,947
+154.9%
0.00%
Q3 2020$526,000
-35.3%
12,139
-20.9%
0.00%
Q2 2020$813,000
+341.8%
15,344
+87.2%
0.00%
Q1 2020$184,000
-24.6%
8,198
-51.0%
0.00%
Q4 2019$244,000
+212.8%
16,720
+50.4%
0.00%
Q3 2019$78,000
+2500.0%
11,115
+3121.7%
0.00%
Q2 2019$3,000
-25.0%
345
-13.8%
0.00%
Q1 2019$4,000
+300.0%
400
+33.3%
0.00%
Q4 2018$1,000
-50.0%
3000.0%0.00%
Q3 2018$2,000
-33.3%
3000.0%0.00%
Q2 2018$3,0003000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders